Additionally, the NCI SBIR & STTR Program has funding opportunities available in a wide range of cancer related topic areas. Some of these grants have upcoming deadlines in July and August 2011. For a complete listing of funding opportunities from the NCI SBIR & STTR Programs, please visit http://sbir.cancer.gov/funding/find_funding.asp.
The NCI SBIR & STTR Programs are structured in three phases:
- Phase I support is normally $150,000 provided over a period of 6 months for SBIR and $100,000 over a period of 1 year for STTR.
- Phase II awards are typically $1 million over 2 years for SBIR and $750,000 over 2 years for STTR. Only Phase I awardees are eligible for a Phase II award.
- Phase II Bridge Awards are provided to previously funded NIH SBIR Phase II awardees to address the funding gap between the end of the Phase II award and the commercialization stage. A total of $3 million over 3 years may be requested from the NCI.
If you are interested in receiving additional information about these funding opportunities or would like to learn more about the NCI SBIR & STTR Programs, please let us know. We are happy to help answer any questions or provide further information.
Thank you in advance for your consideration.
Katie DiOrio
Assistant Account Executive
Feinstein Kean Healthcare | An Ogilvy Company
245 First Street, 14th Floor, Cambridge, MA 02142
d: 617.761.6788 | m: 917.435.0506 | o: 617.577.8110
e: katherine.diorio@fkhealth.com| www.fkhealth.com
